UBS Group’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-124,779
| Closed | -$1.27M | – | 9162 |
|
|
2023
Q3 | $1.27M | Buy |
124,779
+116,685
| +1,442% | +$1.19M | ﹤0.01% | 2910 |
|
|
2023
Q2 | $38K | Buy |
8,094
+3,309
| +69% | +$15.6K | ﹤0.01% | 5547 |
|
|
2023
Q1 | $22.1K | Buy |
4,785
+2,637
| +123% | +$12.2K | ﹤0.01% | 5915 |
|
|
2022
Q4 | $7.8K | Buy |
+2,148
| New | +$7.8K | ﹤0.01% | 7663 |
|
|
2022
Q3 | – | Sell |
-1,652
| Closed | -$8K | – | 10049 |
|
|
2022
Q2 | $8K | Sell |
1,652
-304
| -16% | -$1.47K | ﹤0.01% | 7363 |
|
|
2022
Q1 | $12K | Sell |
1,956
-3,758
| -66% | -$23.1K | ﹤0.01% | 7180 |
|
|
2021
Q4 | $35K | Buy |
+5,714
| New | +$35K | ﹤0.01% | 6135 |
|